Sandoz scoops up Aspen operations and assets in Japan for $330 million
According to the Novartis subsidiary, this acquisition reinforces its strategy to focus on Japan. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 12, 2019 Category: Pharmaceuticals Source Type: news
Lupin offloads Japanese subsidiary for $526 million
The company ' s subsidiary Nanomi B.V. will divest its entire 99.82% stake to private equity fund Unison, which has experience in the healthcare sector. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 12, 2019 Category: Pharmaceuticals Source Type: news
Lonza CEO makes sudden, surprise departure
Lonza investors were reportedly taken aback this week by the surprise announcement that the company ’s CEO is planning to step down. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 12, 2019 Category: Pharmaceuticals Source Type: news
AZ lupus drug hits the mark in late-stage study
AstraZeneca reported positive results this week from a late-stage lupus study. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 12, 2019 Category: Pharmaceuticals Source Type: news
How did the FDA do in 2019? Tell us what you think!
Take our ultra quick survey for a chance to be quoted in our December issue. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 11, 2019 Category: Pharmaceuticals Source Type: news
FDA hands 3rd denial to Lipocine testosterone med
The third time was not the charm for Lipocine ’s male sex hormone treatment. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 11, 2019 Category: Pharmaceuticals Source Type: news
Roche closer to breaking into lucrative SMA market with positive trial results
Positive trial results for an oral drug to treat spinal muscular atrophy (SMA) are bringing Roche one step closer to breaking into the high-cost treatment area. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 11, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 11/8/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 7, 2019 Category: Pharmaceuticals Source Type: news
Purdue shielded from litigation until April
A U.S. bankruptcy judge will approve an order that will extend a stay on more than 2,600 lawsuits that accuse the company and its owners of fueling the opioid crisis. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 7, 2019 Category: Pharmaceuticals Source Type: news
Aurobindo-Sandoz deal pushed back as FTC seeks more info
The deal, originally announced back in September 2018, will not be closed until February 2020 at the earliest. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 7, 2019 Category: Pharmaceuticals Source Type: news
Takeda sells portfolio of drugs for $660 million to German company
The German Stada will acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, Georgia and CIS countries (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 6, 2019 Category: Pharmaceuticals Source Type: news
AstraZeneca invests $1 billion in China
The British drugmaker is launching a fund with China International Capital Corporation and will also begin distributing Sun Pharma cancer drugs in China (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 6, 2019 Category: Pharmaceuticals Source Type: news
Novartis finally wins US approval for its generic Neulasta
The drugmaker ' s biosimilar Ziextenzo was originally rejected by the FDA in 2016 (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 5, 2019 Category: Pharmaceuticals Source Type: news
Thermo Fisher invests $24 million in biologics site in Scotland
The site expansion in Inchinnan, which aims to add large-volume liquid manufacturing capacity for cell culture media, is expected to be completed by June 2021. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 5, 2019 Category: Pharmaceuticals Source Type: news
FDA says ranitidine no more dangerous than ‘smoked meats’
Since all the hoopla surrounding ranitidine began, the FDA has been cautious in giving a final word on how dangerous the levels of NDMA in the drug could be. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 5, 2019 Category: Pharmaceuticals Source Type: news
